BioScience Health Innovations Stock Price, News & Analysis
Company Description
BioScience Health Innovations (BHICD) is a publicly traded company.
On a trailing twelve-month basis, BioScience Health Innovations reported revenue of $5.7M with net income of $642K and diluted earnings per share of $0.06. The company operates at a net profit margin of 11.3%.
This page provides a comprehensive overview of BHICD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BHICD Rankings
Latest News
SEC Filings
BioScience Health Innovations has filed 10 recent SEC filings, including 4 Form 10-Q, 4 Form 8-K, 2 Form 10-K. The most recent filing was submitted on May 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BHICD SEC filings →
Financial Highlights
BioScience Health Innovations generated $5.7M in revenue over the trailing twelve months, retaining a 57.0% gross margin, operating income reached $719K (12.6% operating margin), and net income was $642K, reflecting a 11.3% net profit margin. Diluted earnings per share stood at $0.06. The company generated $172K in operating cash flow.